Optina danazol: Phase IIb data

Data from a subgroup of 106 DME patients based on undisclosed BMI criteria in the double-blind, U.S. Phase IIb OptimEyes trial showed that once-daily oral Optina for 12 weeks improved BCVA from baseli...